# Targeting ER Stress in Vascular Dysfunction

> **NCT04001647** · EARLY_PHASE1 · TERMINATED · sponsor: **Colorado State University** · enrollment: 17 (actual)

## Conditions studied

- Vasodilation
- Arterial Stiffness

## Interventions

- **DRUG:** Acetylcholine
- **DRUG:** Sodium Nitroprusside
- **DRUG:** Ascorbic Acid

## Key facts

- **NCT ID:** NCT04001647
- **Lead sponsor:** Colorado State University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-06-01
- **Primary completion:** 2022-08-16
- **Final completion:** 2022-08-16
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** IRB approval has been withdrawn
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04001647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04001647, "Targeting ER Stress in Vascular Dysfunction". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT04001647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*